COX-2 inhibitors in sports medicine: utility and controversy
- 15 September 2006
- journal article
- Published by BMJ in British Journal of Sports Medicine
- Vol. 40 (11), 895-896
- https://doi.org/10.1136/bjsm.2006.028944
Abstract
Short term use of COX‐2 inhibitors for pain management is recommendedKeywords
This publication has 14 references indexed in Scilit:
- Cerebrospinal Fluid and Plasma Pharmacokinetics of the Cyclooxygenase 2 Inhibitor Rofecoxib in Humans: Single and Multiple Oral Drug AdministrationAnesthesia & Analgesia, 2005
- Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention TrialNew England Journal of Medicine, 2005
- Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma PreventionNew England Journal of Medicine, 2005
- The Effect of Cyclooxygenase-2 Inhibition on Analgesia and Spinal FusionThe Journal of Bone & Joint Surgery, 2005
- Upregulation of Spinal Cyclooxygenase-2 in Rats after Surgical IncisionAnesthesiology, 2004
- Effects of Perioperative Administration of a Selective Cyclooxygenase 2 Inhibitor on Pain Management and Recovery of Function After Knee ReplacementJAMA, 2003
- Nonfatal sports- and recreation-related injuries treated in emergency departments--United States, July 2000-June 2001.2002
- Prostanoids and pain: unraveling mechanisms and revealing therapeutic targetsTrends in Molecular Medicine, 2002
- Telling the brain about painNature, 2001
- Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid ArthritisNew England Journal of Medicine, 2000